Green, Traci C and Bratberg, Jeffrey and Finnell, Deborah S (2020) Opioid use disorder and the COVID 19 pandemic: a call to sustain regulatory easements and further expand access to treatment. Substance Abuse, 41, (2), pp. 147-149. https://doi.org/10.1080/08897077.2020.1752351.
External website: https://www.tandfonline.com/doi/full/10.1080/08897...
Editorial. We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.
.
See also the following links:
The American Journal of Addictions - Editorial: challenges to opioid use disorders during COVID‐19
Annals of Internal Medicine - Collision of the COVID-19 and addiction epidemics
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Viral disease / infection
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Viral disease / infection > Coronavirus (COVID-19)
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
VA Geographic area > International
Repository Staff Only: item control page